Atlas Trials

Ovarian Carcinoma-Enrollment Completed

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ovarian Carcinoma-Enrollment Completed

RecordFirmDate
A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors (NCT02335918)Celldex Therapeutics2015-01-01

Track Ovarian Carcinoma-Enrollment Completed automatically

Every clearance here is in the API, with alerts when new ones post.